Stevens Johnson syndrome toxic epidermal necrolysis: nursing management Stevens Johnson syndrome toxic epidermal necrolysis: initial assessment The BMJ FDA Advisory No. 2019 182*** UNSAFE USE OF GLUTATHIONE AS SKIN LIGHTENING AGENT The Food and Drug Administration (FDA) warns the public on the dangers associated with the use of injectable lightening agents Stevens Johnson Syndrome Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review BMC Endocrine Disorders Springer Nature Link